CellaVision AB (publ) (OTCMKTS:CLVSF) Shares Down 25.6% – Here’s Why

CellaVision AB (publ) (OTCMKTS:CLVSF) traded down 25.6% during mid-day trading on Thursday . The company traded as low as $19.28 and last traded at $19.28. 157 shares traded hands during mid-day trading, a decline of 59% from the average session volume of 383 shares. The stock had previously closed at $25.91.

CellaVision AB (publ) Price Performance

The company’s 50-day simple moving average is $21.56 and its 200 day simple moving average is $23.60.

CellaVision AB (publ) Company Profile

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.